Mesa Laboratories, Inc.
MLAB
$61.66
-$1.43-2.27%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -620.00K | -1.97M | -249.44M | -245.65M | -250.31M |
| Total Depreciation and Amortization | 25.02M | 24.53M | 23.33M | 26.88M | 28.91M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 14.58M | 17.66M | 267.68M | 257.09M | 259.58M |
| Change in Net Operating Assets | -709.00K | 6.90M | 5.78M | 2.11M | 6.76M |
| Cash from Operations | 38.27M | 47.12M | 47.34M | 40.43M | 44.94M |
| Capital Expenditure | -4.37M | -4.25M | -4.03M | -4.34M | -3.19M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 961.00K | -78.74M | -78.74M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -250.00K | -250.00K | -- | -- | -- |
| Cash from Investing | -4.62M | -4.50M | -3.07M | -83.08M | -81.93M |
| Total Debt Issued | 10.50M | 73.47M | 73.47M | 144.47M | 144.47M |
| Total Debt Repaid | -42.56M | -116.12M | -109.68M | -108.94M | -106.50M |
| Issuance of Common Stock | 2.64M | 2.64M | 358.00K | 358.00K | 358.00K |
| Repurchase of Common Stock | -887.00K | -887.00K | -728.00K | -728.00K | -728.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.48M | -3.47M | -3.46M | -3.46M | -3.45M |
| Other Financing Activities | -10.05M | -452.00K | -1.51M | -1.82M | -1.21M |
| Cash from Financing | -43.83M | -44.82M | -41.56M | 29.89M | 32.94M |
| Foreign Exchange rate Adjustments | 2.98M | 1.31M | 21.00K | 1.48M | 150.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.19M | -893.00K | 2.73M | -11.28M | -3.90M |